These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 19733912)

  • 1. Which depressive symptoms remain after response to cognitive therapy of depression and predict relapse and recurrence?
    Taylor DJ; Walters HM; Vittengl JR; Krebaum S; Jarrett RB
    J Affect Disord; 2010 Jun; 123(1-3):181-7. PubMed ID: 19733912
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Deterioration in psychosocial functioning predicts relapse/recurrence after cognitive therapy for depression.
    Vittengl JR; Clark LA; Jarrett RB
    J Affect Disord; 2009 Jan; 112(1-3):135-43. PubMed ID: 18539337
    [TBL] [Abstract][Full Text] [Related]  

  • 3. How much cognitive therapy, for which patients, will prevent depressive relapse?
    Jarrett RB; Vittengl JR; Clark LA
    J Affect Disord; 2008 Dec; 111(2-3):185-92. PubMed ID: 18358541
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Residual symptoms after remission of major depressive disorder with citalopram and risk of relapse: a STAR*D report.
    Nierenberg AA; Husain MM; Trivedi MH; Fava M; Warden D; Wisniewski SR; Miyahara S; Rush AJ
    Psychol Med; 2010 Jan; 40(1):41-50. PubMed ID: 19460188
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Longitudinal social-interpersonal functioning among higher-risk responders to acute-phase cognitive therapy for recurrent major depressive disorder.
    Vittengl JR; Clark LA; Thase ME; Jarrett RB
    J Affect Disord; 2016 Jul; 199():148-56. PubMed ID: 27104803
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Residual symptoms and recurrence during maintenance treatment of late-life depression.
    Dombrovski AY; Mulsant BH; Houck PR; Mazumdar S; Lenze EJ; Andreescu C; Cyranowski JM; Reynolds CF
    J Affect Disord; 2007 Nov; 103(1-3):77-82. PubMed ID: 17321595
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stable remission and recovery after acute-phase cognitive therapy for recurrent major depressive disorder.
    Vittengl JR; Clark LA; Thase ME; Jarrett RB
    J Consult Clin Psychol; 2014 Dec; 82(6):1049-59. PubMed ID: 25045908
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of continuation treatment on residual symptoms in late-life depression: how well is "well"?
    Opdyke KS; Reynolds CF; Frank E; Begley AE; Buysse DJ; Dew MA; Mulsant BH; Shear MK; Mazumdar S; Kupfer DJ
    Depress Anxiety; 1996-1997; 4(6):312-9. PubMed ID: 9166659
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Do comorbid social and other anxiety disorders predict outcomes during and after cognitive therapy for depression?
    Vittengl JR; Clark LA; Smits JAJ; Thase ME; Jarrett RB
    J Affect Disord; 2019 Jan; 242():150-158. PubMed ID: 30176494
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Residual symptoms after a treated major depressive disorder: in practice ambulatory observatory carried out of city].
    Mouchabac S; Ferreri M; Cabanac F; Bitton M
    Encephale; 2003; 29(5):438-44. PubMed ID: 14615693
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preventing recurrent depression using cognitive therapy with and without a continuation phase: a randomized clinical trial.
    Jarrett RB; Kraft D; Doyle J; Foster BM; Eaves GG; Silver PC
    Arch Gen Psychiatry; 2001 Apr; 58(4):381-8. PubMed ID: 11296099
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The prevalence and severity of depressive symptoms along the spectrum of unipolar depressive disorders: a post hoc analysis.
    Rakofsky JJ; Schettler PJ; Kinkead BL; Frank E; Judd LL; Kupfer DJ; Rush AJ; Thase ME; Yonkers KA; Rapaport MH
    J Clin Psychiatry; 2013 Nov; 74(11):1084-91. PubMed ID: 24330894
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cognitive reactivity, dysfunctional attitudes, and depressive relapse and recurrence in cognitive therapy responders.
    Jarrett RB; Minhajuddin A; Borman PD; Dunlap L; Segal ZV; Kidner CL; Friedman ES; Thase ME
    Behav Res Ther; 2012 May; 50(5):280-6. PubMed ID: 22445946
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Which symptoms predict recurrence of depression in women treated with maintenance interpersonal psychotherapy?
    Dombrovski AY; Cyranowski JM; Mulsant BH; Houck PR; Buysse DJ; Andreescu C; Thase ME; Mallinger AG; Frank E
    Depress Anxiety; 2008; 25(12):1060-6. PubMed ID: 18781665
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predictors of longitudinal outcomes after unstable response to acute-phase cognitive therapy for major depressive disorder.
    Vittengl JR; Clark LA; Thase ME; Jarrett RB
    Psychotherapy (Chic); 2015 Jun; 52(2):268-77. PubMed ID: 25985046
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Initial Steps to inform selection of continuation cognitive therapy or fluoxetine for higher risk responders to cognitive therapy for recurrent major depressive disorder.
    Vittengl JR; Anna Clark L; Thase ME; Jarrett RB
    Psychiatry Res; 2017 Jul; 253():174-181. PubMed ID: 28388454
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Moderators of continuation phase cognitive therapy's effects on relapse, recurrence, remission, and recovery from depression.
    Vittengl JR; Clark LA; Jarrett RB
    Behav Res Ther; 2010 Jun; 48(6):449-58. PubMed ID: 20163785
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of adding cognitive therapy to fluoxetine dose increase on risk of relapse and residual depressive symptoms in continuation treatment of major depressive disorder.
    Perlis RH; Nierenberg AA; Alpert JE; Pava J; Matthews JD; Buchin J; Sickinger AH; Fava M
    J Clin Psychopharmacol; 2002 Oct; 22(5):474-80. PubMed ID: 12352270
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ten-year prospective follow-up study of the naturalistic course of dysthymic disorder and double depression.
    Klein DN; Shankman SA; Rose S
    Am J Psychiatry; 2006 May; 163(5):872-80. PubMed ID: 16648329
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Could Treatment Matching Patients' Beliefs About Depression Improve Outcomes?
    Vittengl JR; Clark LA; Thase ME; Jarrett RB
    Behav Ther; 2019 Jul; 50(4):765-777. PubMed ID: 31208686
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.